Search
for

    Sort by

    Research 871–900 of 1000+

    1. International collaboration and rapid harmonization across dermatologic COVID-19 registries Journal of the American Academy of Dermatology · 2020 · 14 citations
    2. Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19. PubMed · 2024
    3. Tofacitinib Treatment in Patients With Active COVID-19 Infection Curēus · 2021 · 2 citations
    4. Impact of Telemedicine on Health Expenditures During the COVID-19 Pandemic in Japan: Quasi-Experimental Study Journal of Medical Internet Research · 2025
    5. Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees Journal of Infection · 2022 · 16 citations
    6. Knowledge, Attitude, and Practice Regarding COVID-19 Skin Manifestations among Doctors Working at Khartoum Dermatology and Venereology Teaching Hospital, 2021 Sudan Journal of Medical Sciences · 2024
    7. Contract cheating websites in Spain (2019–2024): web traffic trends during COVID-19 and the rise of generative AI International Journal for Educational Integrity · 2026
    8. Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates Public health · 2024
    9. Telogen effluvium in the new SARS‐CoV‐2 era International Journal of Dermatology · 2021 · 4 citations
    10. Eflúvio telógeno como sintoma da “Covid longa” em pacientes pré-infectados por SARS-CoV-2: uma revisão integrativa de literatura Research, Society and Development · 2022
    11. Examining Alopecia through Selected Case Studies in Bangladesh European journal of medical and health sciences · 2021
    12. Prevalence and Clinical Characteristics of Androgenetic Alopecia in Nepalese Patients: A Cross-sectional Observational Study Civil Medical Journal · 2023
    13. Excessive hair loss as a complication after infection with SARS-CoV-2 virus Aesthetic Cosmetology and Medicine · 2021
    14. Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials SKIN The Journal of Cutaneous Medicine · 2025
    15. Epidemiological Analysis of Alopecia in Migrant Communities at Dr. Hair™ Clinics 2025
    16. Features of hemorheological disorders in patients with alopecia associated with coronavirus infection Голова и шея. · 2025
    17. A Study of the Clinical Patterns of Hair Loss in Female Patients Clinical dermatology review (Print) · 2024
    18. A Cross-Sectional Analysis of Psychological and Dermatologic Manifestations Post-February 6 Earthquakes in Dermatology Patients Annals of Dermatology · 2026
    19. Long COVID? What is that? ˜The œLancet. Respiratory medicine · 2023 · 2 citations
    20. Facial Dermatoses in the Age of Masks: Acne, Eczema and the New Maskne JUNIOR RESEARCHERS · 2025
    21. PLATELET RİCH PLASMA RESULTS IN THE TREATMENT OF FEMUR HEAD AVASCULAR NECROSIS Bozok Tıp Dergisi · 2024
    22. The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients Frontiers in Cellular and Infection Microbiology · 2023 · 6 citations
    23. Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis BDJ Open · 2025
    24. Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data Dermatology and Therapy · 2023
    25. JCD — Editorial Commentary, May, 2021 Journal of Cosmetic Dermatology · 2021
    26. Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study Clinical Cosmetic and Investigational Dermatology · 2024 · 4 citations
    27. Kaleidoscope The British Journal of Psychiatry · 2021
    28. The most recent advances in understanding and managing hidradenitis suppurativa F1000Research · 2020 · 28 citations
    29. Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2 Journal of the European Academy of Dermatology and Venereology · 2024
    30. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) American Journal of Clinical Dermatology · 2023 · 20 citations